Transcriptome analysis of CD34+ cells from myelodysplastic syndrome patients.
Sign Up to like & getrecommendations! Published in 2017 at "Leukemia research"
DOI: 10.1016/j.leukres.2017.09.003
Abstract: The myelodysplastic syndrome (MDS) represents a heterogeneous group of clonal hematologic stem cell disorders with the characteristic of ineffective hematopoiesis leading to low blood counts, and a risk of progression to acute myeloid leukemia (AML).… read more here.
Keywords: analysis; refractory anemia; mds subtypes; myelodysplastic syndrome ... See more keywords